Protagonist Therapeutics, Inc. (PTGX)
124.70
-0.13
(-0.10%)
USD |
NASDAQ |
Nov 17, 16:00
124.70
0.00 (0.00%)
After-Hours: 20:00
Protagonist Therapeutics Price : 124.70 for Nov. 17, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 130.51 | 131.28 | 124.00 | 124.83 | 565202.0 |
| Nov 13, 2026 | 134.03 | 134.90 | 130.64 | 130.95 | 759916.0 |
| Nov 12, 2026 | 134.16 | 138.82 | 131.26 | 134.38 | 542900.0 |
| Nov 11, 2026 | 136.51 | 136.98 | 132.03 | 134.86 | 332593.0 |
| Nov 10, 2026 | 134.21 | 137.97 | 133.35 | 136.26 | 528492.0 |
| Nov 09, 2026 | 135.02 | 137.93 | 131.31 | 135.90 | 607112.0 |
| Nov 06, 2026 | 135.26 | 138.40 | 128.00 | 132.04 | 972946.0 |
| Nov 05, 2026 | 142.56 | 143.30 | 134.39 | 135.26 | 584679.0 |
| Nov 04, 2026 | 145.61 | 145.61 | 138.39 | 143.37 | 777232.0 |
| Nov 03, 2026 | 140.73 | 144.26 | 139.91 | 140.24 | 674723.0 |
| Nov 02, 2026 | 145.74 | 146.00 | 139.35 | 139.37 | 486660.0 |
| Oct 30, 2026 | 144.34 | 146.00 | 142.54 | 144.85 | 322566.0 |
| Oct 29, 2026 | 144.03 | 146.44 | 142.87 | 144.34 | 325558.0 |
| Oct 28, 2026 | 139.35 | 143.26 | 138.29 | 142.14 | 318459.0 |
| Oct 27, 2026 | 140.08 | 142.37 | 137.91 | 141.12 | 865926.0 |
| Oct 26, 2026 | 139.24 | 142.00 | 137.30 | 140.32 | 823278.0 |
| Oct 23, 2026 | 136.89 | 139.52 | 135.00 | 138.43 | 409357.0 |
| Oct 22, 2026 | 137.49 | 141.38 | 136.07 | 139.53 | 404387.0 |
| Oct 21, 2026 | 139.71 | 141.85 | 137.96 | 138.08 | 990174.0 |
| Oct 20, 2026 | 135.87 | 140.82 | 134.32 | 137.99 | 774485.0 |
| Oct 19, 2026 | 130.09 | 134.97 | 128.01 | 134.44 | 654178.0 |
| Oct 16, 2026 | 136.16 | 136.56 | 126.39 | 128.75 | 886813.0 |
| Oct 15, 2026 | 136.72 | 139.11 | 136.02 | 136.55 | 707740.0 |
| Oct 14, 2026 | 138.06 | 141.13 | 135.62 | 136.28 | 679101.0 |
| Oct 13, 2026 | 146.00 | 146.00 | 137.81 | 138.49 | 1.032M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 292.80 |
| Nektar Therapeutics | 35.96 |
| Agios Pharmaceuticals, Inc. | 29.88 |
| Keros Therapeutics, Inc. | 11.32 |
| Shattuck Labs, Inc. | 4.595 |
Price Related Metrics
| PE Ratio | 26.41 |
| PS Ratio | 15.67 |
| PEG Ratio | 0.0410 |
| Price to Book Value | 7.496 |
| Price to Free Cash Flow | 79.19 |
| Earnings Yield | 3.79% |
| Market Cap | 8.132B |
| PEGY Ratio | 0.0410 |
| Operating PE Ratio | 26.75 |
| Normalized PE Ratio | 26.41 |